Prognostic Value of Mid-Regional Pro-Adrenomedullin Levels Taken on Admission and Discharge in Non-ST-Elevation Myocardial Infarction. The LAMP (Leicester Acute Myocardial Infarction Peptide) II Study

Journal of the American College of Cardiology

Volumn 56, Issue 2, 2010, Pages 125-133

  Dhillon, Onkar S ^a   Khan, Sohail Q ^a   Narayan, Hafid K ^a   Ng, Kelvin H ^a   Struck, Joachim ^b   Quinn, Paulene A ^a   Morgenthaler, Nils G ^b   Squire, Iain B ^a   Davies, Joan E ^a   Bergmann, Andreas ^b   Ng, Leong L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

adrenomedullin; Global Registry of Acute Coronary Events score; myocardial infarction; N terminal pro B type natriuretic peptide; prognosis

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; PROADRENOMEDULLIN;

AGED; ARTICLE; BLOOD SAMPLING; CLINICAL DECISION MAKING; DEATH; DIURETIC THERAPY; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADRENOMEDULLIN; AGED; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PATIENT ADMISSION; PATIENT DISCHARGE; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS;

EID: 77953884955     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.01.060     Document Type: Article

References (24)

1. Hasdai D., Behar S., Wallentin L., et al. Prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 23 (2002) 1190-1201
2. Terkelsen C.J., Lassen J.F., Norgaard B.L., et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 26 (2005) 18-26
3. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 50 (2007) e1-e157
4. Eagle K.A., Lim M.J., Dabbous O.H., et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month post discharge death in an international registry. JAMA 291 (2004) 2727-2733
5. Omland T., Persson A., Ng L., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106 (2002) 2913-2918
6. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
7. Kato J., Kobayashi K., Etoh T., et al. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 81 (1996) 180-183
8. Miyao Y., Nishikimi T., Goto Y., et al. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart 79 (1998) 39-44
9. Lainchbury J.G., Cooper G.J., Coy D.H., et al. Adrenomedullin: a hypotensive hormone in man. Clin Sci Colch 92 (1997) 467-472
10. Vari R.C., Adkins S.D., and Samson W.K. Renal effects of adrenomedullin in the rat. Proc Soc Exp Biol Med 211 (1996) 178-183
11. Pousset F., Masson F., Chavirovskaia O., et al. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur Heart J 21 (2000) 1009-1014
12. Struck J., Tao C., Morgenthaler N.G., and Bergmann A. Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 25 (2004) 1369-1372
13. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., and Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 194 (1993) 720-725
14. Khan S.Q., O'Brien R.J., Struck J., et al. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction. The LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 49 (2007) 1525-1532
15. Thygesen K., Alpert J.S., and White H.D. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 50 (2007) 2173-2195
16. Smilde T.D., van Veldhuisen D.J., Navis G., Voors A.A., and Hillege H.L. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 114 (2006) 1572-1580
17. Morgenthaler N.G., Struck J., Alonso C., and Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51 (2005) 1823-1829
18. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., and Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27 (2008) 157-172
19. Niu P., Shindo T., Iwata H., et al. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage. Circulation 109 (2004) 1789-1794
20. Nagaya N., Goto Y., Satoh T., et al. Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. J Cardiovasc Pharmacol 39 (2002) 754-760
21. Nagaya N., Satoh T., Nishikimi T., et al. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 101 (2000) 498-503
22. Kato J., Tsuruda T., Kita T., Kitamura K., and Eto T. Adrenomedullin: a protective factor for blood vessels. Arterioscler Thromb Vasc Biol 25 (2005) 2480-2487
23. Katayama T., Nakashima H., Furudono S., Honda Y., Suzuki S., and Yano K. Evaluation of neurohumoral activation (adrenomedullin, BNP, catecholamines, etc.) in patients with acute myocardial infarction. Intern Med 43 (2004) 1015-1022
24. Mehta S.R., Granger C.B., Boden W.E., et al., TIMACS Investigators. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 360 (2009) 2165-2175